Real-world Study of Inetetamab in HER2-positive Metastatic Breast Cancer
Condition(s):HER2-positive Metastatic Breast CancerLast Updated:March 12, 2024Completed
Hide Studies Not Open or Pending
Condition(s):HER2-positive Metastatic Breast CancerLast Updated:March 12, 2024Completed
Condition(s):Non Small Cell Lung CancerLast Updated:March 7, 2024Not yet recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:November 22, 2023Not yet recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:July 27, 2023Not yet recruiting
Condition(s):For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple MethodLast Updated:March 20, 2023Not yet recruiting
Condition(s):Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal CancerLast Updated:February 9, 2023Not yet recruiting
Condition(s):Chemotherapy-induced ThrombocytopeniaLast Updated:January 18, 2023Completed
Condition(s):Breast Neoplasm FemaleLast Updated:July 12, 2022Not yet recruiting
Condition(s):Breast CancerLast Updated:January 14, 2022Unknown status
Condition(s):NSCLC; EGF-R Positive Non-Small Cell Lung CancerLast Updated:December 10, 2021Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.